Skip to content

Effect of different degrees of neuromuscular blockade on the diameter of optic nerve sheath in patients undergoing laparoscopic cholecystectomy combined with choledocholithotomy: a randomized controlled trial.

Effect of different degrees of neuromuscular blockade on the diameter of optic nerve sheath in patients undergoing laparoscopic cholecystectomy combined with choledocholithotomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034071
Enrollment
Unknown
Registered
2020-06-22
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis

Interventions

Deep neuromuscular blockade group:Deep neuromuscular blockade
Moderate neuromuscular blockade group:Moderate neuromuscular blockade

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Laparoscopic cholecystectomy combined with choledocholithotomy under general anesthesia in the Second Affiliated Hospital of Nanchang University; 2. ASA I-III patients; 3. Patients aged 45-65 years old with body mass index of 18-30kg / m2; 4. Patients who are ethical, volunteer and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with current ophthalmic diseases (glaucoma, diabetic retinopathy, cataract, orbital tumor, optic nerve, diseases affecting the diameter of optic nerve sheath and retinal detachment); 2. Patients who have received ophthalmic operation; 3. Patients with preoperative intracranial hypertension, craniocerebral surgery and disease history; 4. Patients who have been allergic to anesthetics, muscle relaxants, family history of malignant hyperthermia and neuromuscular history; 5. Patients with primary hepatolithiasis and hepatobiliary system tumor, and acute obstructive suppurative cholangitis and pancreatitis; 6. Patients with serious heart and lung diseases, liver and kidney dysfunction and mental diseases, language communication disorders and refusing to participate in the experiment; 7. Patients with serious complications during operation (bleeding volume greater than 1000ml, severe anaphylactic shock, etc.).

Design outcomes

Primary

MeasureTime frame
Optic nerve sheath diameter;

Secondary

MeasureTime frame
Cerebral oxygen saturation;Arterial carbon dioxide partial pressure;Central venous pressure;Tofr0.9 time;

Countries

China

Contacts

Public ContactZhou Zhidong

The Second Affiliated Hospital of Nanchang University

dongdongzhi@163.com+86 13970932882

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026